Lin H, Liu Q, Zeng X, Yu W, et al. Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study. BMC Cancer 2021;21:399.
PMID: 33849473